These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 33572320)

  • 1. Overview of MMP-13 as a Promising Target for the Treatment of Osteoarthritis.
    Hu Q; Ecker M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of matrix metalloproteinases in osteoarthritis pathogenesis: An updated review.
    Mehana EE; Khafaga AF; El-Blehi SS
    Life Sci; 2019 Oct; 234():116786. PubMed ID: 31445934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gumiganghwal-tang ameliorates cartilage destruction via inhibition of matrix metalloproteinase.
    Kim MH; Choi Y; Ahn KS; Um JY; Lee SG; Hahm DH; Yang WM
    J Ethnopharmacol; 2020 Oct; 261():113074. PubMed ID: 32534115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of Nebivolol against interleukin-1β (IL-1β)-induced type II collagen destruction mediated by matrix metalloproteinase-13 (MMP-13).
    Li Z; Liu B; Zhao D; Wang B; Liu Y; Zhang Y; Tian F; Li B
    Cell Stress Chaperones; 2017 Nov; 22(6):767-774. PubMed ID: 28512729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxytocin prevents cartilage matrix destruction via regulating matrix metalloproteinases.
    Wu Y; Wu T; Xu B; Xu X; Chen H; Li X
    Biochem Biophys Res Commun; 2017 May; 486(3):601-606. PubMed ID: 28238786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On-demand release of a selective MMP-13 blocker from an enzyme-responsive injectable hydrogel protects cartilage from degenerative progression in osteoarthritis.
    Roy HS; Murugesan P; Kulkarni C; Arora M; Nagar GK; Guha R; Chattopadhyay N; Ghosh D
    J Mater Chem B; 2024 Jun; 12(22):5325-5338. PubMed ID: 38669084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of the collagen receptor discoidin domain receptor 2 in articular cartilage as a key event in the pathogenesis of osteoarthritis.
    Xu L; Peng H; Glasson S; Lee PL; Hu K; Ijiri K; Olsen BR; Goldring MB; Li Y
    Arthritis Rheum; 2007 Aug; 56(8):2663-73. PubMed ID: 17665456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel selective MMP-13 inhibitors reduce collagen degradation in bovine articular and human osteoarthritis cartilage explants.
    Piecha D; Weik J; Kheil H; Becher G; Timmermann A; Jaworski A; Burger M; Hofmann MW
    Inflamm Res; 2010 May; 59(5):379-89. PubMed ID: 19902332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-articular injection of microRNA-140 (miRNA-140) alleviates osteoarthritis (OA) progression by modulating extracellular matrix (ECM) homeostasis in rats.
    Si HB; Zeng Y; Liu SY; Zhou ZK; Chen YN; Cheng JQ; Lu YR; Shen B
    Osteoarthritis Cartilage; 2017 Oct; 25(10):1698-1707. PubMed ID: 28647469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of matrix metalloproteinases 2, 9, and 13 by activated protein C in human osteoarthritic cartilage chondrocytes.
    Jackson MT; Moradi B; Smith MM; Jackson CJ; Little CB
    Arthritis Rheumatol; 2014 Jun; 66(6):1525-36. PubMed ID: 24574263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights on the MMP-13 regulatory network in the pathogenesis of early osteoarthritis.
    Li H; Wang D; Yuan Y; Min J
    Arthritis Res Ther; 2017 Nov; 19(1):248. PubMed ID: 29126436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a selective matrix metalloproteinase 13 (MMP-13) inhibitor for the treatment of Osteoarthritis.
    Bendele AM; Neelagiri M; Neelagiri V; Sucholeiki I
    Eur J Med Chem; 2021 Nov; 224():113666. PubMed ID: 34245949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.
    Baragi VM; Becher G; Bendele AM; Biesinger R; Bluhm H; Boer J; Deng H; Dodd R; Essers M; Feuerstein T; Gallagher BM; Gege C; Hochgürtel M; Hofmann M; Jaworski A; Jin L; Kiely A; Korniski B; Kroth H; Nix D; Nolte B; Piecha D; Powers TS; Richter F; Schneider M; Steeneck C; Sucholeiki I; Taveras A; Timmermann A; Van Veldhuizen J; Weik J; Wu X; Xia B
    Arthritis Rheum; 2009 Jul; 60(7):2008-18. PubMed ID: 19565489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chicken collagen type II reduces articular cartilage destruction in a model of osteoarthritis in rats.
    Xu D; Shen W
    West Indian Med J; 2007 Jun; 56(3):202-7. PubMed ID: 18072397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective MMP-13 Inhibitors: Promising Agents for the Therapy of Osteoarthritis.
    Wan Y; Li W; Liao Z; Yan M; Chen X; Tang Z
    Curr Med Chem; 2020; 27(22):3753-3769. PubMed ID: 30556497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression level of proteoglycan, collagen and type II collagen in osteoarthritis rat model is promoted and degradation of cartilage is prevented by glucosamine methyl ester.
    Wang XX; Cai L
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3609-3616. PubMed ID: 29917216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Research Advances in Selective Matrix Metalloproteinase-13 Inhibitors as Anti-Osteoarthritis Agents.
    Xie XW; Wan RZ; Liu ZP
    ChemMedChem; 2017 Aug; 12(15):1157-1168. PubMed ID: 28722301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking of the P2X7 receptor inhibits the activation of the MMP-13 and NF-κB pathways in the cartilage tissue of rats with osteoarthritis.
    Hu H; Yang B; Li Y; Zhang S; Li Z
    Int J Mol Med; 2016 Dec; 38(6):1922-1932. PubMed ID: 27748894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of EGb761 on the expression of matrix metalloproteinases (MMPs) and cartilage matrix destruction.
    Wang X; Zhao X; Tang S
    Cell Stress Chaperones; 2015 Sep; 20(5):781-6. PubMed ID: 26045200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of FGF-2 and FGF receptor antagonists on MMP enzymes, aggrecan, and type II collagen in primary human OA chondrocytes.
    Nummenmaa E; Hämäläinen M; Moilanen T; Vuolteenaho K; Moilanen E
    Scand J Rheumatol; 2015; 44(4):321-30. PubMed ID: 25743336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.